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The interaction between the respiratory syncytial virus (RSV) polymerase complex and lipid rafts was examined in HEp2 cells. Lipid-raft
membranes were prepared from virus-infected cells and their protein content was analysed by Western blotting and mass spectrometry. This
analysis revealed the presence of the N, P, L, M2-1 and M proteins. However, these proteins appeared to differ from one another in their
association with these structures, with the M2-1 protein showing a greater partitioning into raft membranes compared to that of the N, P or M
proteins. Determination of the polymerase activity profile of the gradient fractions revealed that 95% of the detectable viral enzyme activity
was associated with lipid-raft membranes. Furthermore, analysis of virus-infected cells by confocal microscopy suggested an association
between these proteins and the raft-lipid, GM1. Together, these results provide evidence that the RSV polymerase complex is able to
associate with lipid rafts in virus-infected cells.
D 2004 Elsevier Inc. All rights reserved.
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The mature respiratory syncytial virus (RSV) particle
comprises a ribonucleoprotein (RNP) core that is formed by
the interaction of the viral genomic RNA with the
nucleocapsid (N) protein, the phosphoprotein (P), the
M2-1 protein and the large (L) polymerase subunit. This
structure is surrounded by a lipid envelope that is derived
from the host cell in which the virus glycoproteins are
embedded. An additional virus protein, the matrix (M)
protein, is located between the viral envelope and the RNP
(Arslanagic et al., 1996; Bachi and Howe, 1973; Brown et
al., 2002a; Norrby et al., 1970; Parry et al., 1979; Roberts et
al., 1995). Although the cellular processes that lead to0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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involvement of lipid-raft microdomains during virus assem-
bly has been demonstrated (Brown et al., 2002a, 2002b;
Jeffree et al., 2003; McCurdy and Graham, 2003). However,
it is not known to what extent lipid rafts are involved in
other processes that take place during virus infection, such
as transcription and replication of the virus genome. An
association between the cellular membranes and the
polymerase complexes of several positive-stranded RNA
viruses has been demonstrated and it is envisaged that this
interaction may facilitate recruitment of the virus and host-
cell factors that are required for polymerase activity (e.g.,
HCV, reviewed in Penin et al., 2004). In the case of RSV,
the minimal functional polymerase activity requires an
association between the N, P and L proteins and the virus
genome (Collins et al., 1996; Grosfeld et al., 1995; Yu et al.,
1995). An additional viral protein, the M2-1 protein, is a
transcription anti-termination factor that is required for
efficient transcription of the viral genome by the polymerase04) 147–157
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Hardy et al., 1999; Mason et al., 2003). The interactions that
occur both among the individual proteins of the polymerase
complex and between these proteins and the virus RNA
have been largely characterised (reviewed in Easton et al.,
2004). Although the virus polymerase requires host factors
for activity (Barik, 1992; Burke et al., 1998, 2000), there is
no evidence for an association between the RSV polymer-
ase complex and cellular membranes. We have examined
the membrane association of the RSV polymerase complex
in virus-infected cells using a combination of molecular
techniques and a novel proteomic approach. The results
presented in this report provide the first direct evidence that
this complex is associated with host-cell membranes that
exhibit properties consistent with those of lipid-raft
membranes.Results and discussion
Components of the RSV replicase associate with lipid rafts
Total membranes prepared from virus-infected Hep2
cells were extracted with 1% Triton X-100 and fractionated
in a sucrose step gradient (35% and 5% sucrose) as
described in Materials and methods. The gradients were
then examined for the presence of the virus proteins that
constitute the polymerase complex using two complemen-
tary techniques. In the first method, the location of specific
virus proteins in the gradient fractions was determined by
Western blotting using relevant antibodies. In the second
method, the protein content in the lipid-raft fraction was
examined directly by two-dimensional nanoflow liquidFig. 1. Flotation gradient analysis of RSV-infected cell membranes. Membranes w
analysis as described in Materials and methods. Specific proteins were located in
Distribution of the M2-1, P, N and M proteins after Triton extraction where 1 is th
indicated. The distribution of the raft-marker caveolin-1 (cav-1), the non-raft marke
(B) Estimation of the levels of each RSV protein within the lipid-raft fraction obchromatography mass spectrometry (2D-nLC-MSMS). In
this approach, a complex protein mixture is digested using a
specific protease, such as trypsin, and the resulting peptides
separated by nano-scale liquid chromatography. The masses
of these peptides are then determined by mass spectrometry
and matched against a database of peptide masses from
known proteins as described in Materials and methods. This
procedure enables protein mixtures to be analysed in an
unbiased manner and has been used recently to characterise
the proteins that associate with lipid-raft membranes in
several different cell lines (Elortza et al., 2003; Foster et al.,
2003; Saeki et al., 2003; von Haller et al., 2001).
The presence of the virus proteins and specific host-cell
proteins in the gradient fractions were detected by Western
blot analysis (Fig. 1A). In this analysis, the raft marker
caveolin-1 (cav-1) (Sargiacomo et al., 1993) was detected
almost exclusively in the raft fraction whereas transferrin
receptor (tfr), a non-raft marker, was found almost
exclusively in the non-raft fraction of the gradient. This
therefore demonstrated the specific and efficient solubilisa-
tion of non-raft proteins in the flotation gradient. Further
examination of the flotation gradient fractions revealed the
presence of the N, P and M proteins, confirming recent
observations (McCurdy and Graham, 2003), and the M2-1
protein in the lipid-raft fraction (Fig. 1A). A comparison of
the relative protein levels in the raft- and non-raft fractions
suggested that each protein differed in its ability to interact
with raft membranes (Fig. 1B). The M2-1 protein was
present in the raft-fraction at relatively high levels account-
ing for approximately 80% of the total M2-1 protein
detected in the flotation gradient whereas the P and N
proteins accounted for approximately 20% and 30%,
respectively (Fig. 1B). In addition, actin was also detectedere prepared from virus-infected cells and examined by flotation gradien
gradient fractions by Western blot analysis using relevant antibodies. (A
e top fraction and 11 the bottom fraction. The raft and non-raft fractions are
r transferrin receptor (tfr) and actin within the flotation gradient can be seen
tained by densitometry.t
)
.
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below.
Using the second technique, total proteins in the lipid-raft
fraction isolated from mock- and virus-infected cells were
trypsinised and the individual peptides separated by liquid
chromatography. These peptides are sequentially frag-
mented by ionisation, such that each individual peptide
yields a series of smaller peptides that differ in mass
depending upon the number and type of amino acid residue
that has been removed. This difference in mass allows the
sequence to be determined for each peptide isolated from
the original trypsin digestion. The resulting masses are then
compared with those expected from a theoretical fragmen-
tation pattern and depending on the match, a score is
assigned. An example of the quality of the sequence data
obtained from the MSMS fragmentation procedure can be
seen for one particular MSMS spectrum derived from the
peptide ELANVNILVK. This sequence is present in the
RSV M protein and has a mass 1111.6 Daltons (Da). The
fragmentation of this peptide yields nine smaller peptides,
ranging from 983.62 to 147.11 Da, that are detected as ion
peaks in the mass spectrum as y(1) to y(9) (Fig. 2A). A
comparison of the experimental MSMS data from this
peptide with the theoretical fragmentation data generated by
Mascot shows that the actual and calculated masses of the
peptide fragments from this peptide are identical, coveringFig. 2. An example of the MSMS data generated from the peptide ELANVNILVK
search by the BioAnalyst software. The matched ion peaks are also labelled with
can be seen in the raw data, giving a high confidence identification. (B) The table
peptide sequence by MASCOT. Numbers in bold in the table are matches of theothe full sequence of the peptide (Fig. 2B). The peptide
sequences obtained by this method were compared with the
human gene sequences deposited within the NCBInr data-
base to evaluate the occurrence of Hep2 cell proteins. No
significant differences in the detection of specific host-cell
proteins between mock- and virus-infected cells were noted.
Approximately 200 host-cell proteins were identified, which
included a range of proteins that are known to associate with
lipid-raft membranes such as placental alkaline phosphatase
(PLAP), stomatin and flotillin and a variety of cytoskeleton-
related proteins (Table 1A).
Analysis of the peptide sequences identified by 2D-nLC-
MSMS against the virus sequences deposited within the
NCBInr database revealed several unique peptides that
corresponded to expected tryptic peptides from the N, M, P,
F, L and M2-1 proteins (Table 1B). Many of these peptides
had individual ion scores N40 (Fig. 3), indicating sequence
identity or close homology. All six RSV proteins identified
produced high total mascot scores of between 249 and 836
in this analysis (see Table 1B). Location of the matched
peptide sequences within the respective virus proteins
reveals sequence coverage from 5% (L protein) to 52% (P
protein) (Table 1B) with a good distribution of matched
peptides across the whole sequence (Fig. 4). These peptide
sequences did not correspond to any host proteins in the
NCBInr database and they were not identified in the 2D-. (A) The spectrum shows the raw MSMS data after export into the Mascot
the relevant ion identification on the spectrum. A complete series of Y ions
is the expected MSMS masses (Da) generated in a theoretical MSMS of the
retical to the raw data.
Table 1
Proteins identified in the raft fractions prepared from virus-infected cells
A
Protein Accession
no.
Mascot
score
Total
peptides
matched
PLAP 1EW2_A 1161 21
Porin 3HM AAB20246 765 11
NAP-22 NP006308 526 9
g-Actin ATBOG 490 23
Keratin 8 A34720 374 24
Hypothetical
protein
FLJ10709
NP060658 318 8
h-Actin CAA45026 290 20
Vimentin A25074 237 20
Stomatin AAC50296 273 7
Keratin 17 NP_000413 151 16
Flotillin-2 NP004466 166 6
a-Actin ATHUSM 128 7
Flotillin-1 NP005794 148 3
B
Protein Mass
(Da)
PI
(pH)
Accession
no.
Mascot
score
Peptides
matched
Sequence
coverage
(%)
N 43424 6.88 P03418 836 12 43
M 28969 8.66 P03419 644 10 48
P 27117 4.52 ACC55965 428 9 52
F 63325 9.10 CAA26143 332 6 13
L 250226 8.97 AAF71286 286 9 5
M2-1 22140 9.13 P045454 249 5 30
Summary of the data obtained for (A) representative host-cell proteins and
(B) virus proteins identified by 2D-nLC-MSMS. The predicted molecular
mass (Mass) and isoelectric point (PI) for each protein without any post-
translational modifications is shown. The Mascot score = 10 log( P),
where P is the probability that the observed match is a random event. The
number of peptides identified that match the sequence of the protein in
question is shown, as is the sequence coverage of these peptides. Known
raft-associated proteins are in bold text.
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mock-infected cells.
The Western blotting and 2D-nLC-MSMS results sug-
gested that the components comprising the functional virus
polymerase, i.e., the N, P, M2-1 and L proteins (Collins et
al., 1996; Fearns and Collins, 1999; Grosfeld et al., 1995;
Yu et al., 1995) are able associate with lipid-raft membranes.
Although immunological reagents are available to detect the
N, P and M2-1 proteins, a major problem in L protein
detection, particularly in RSV-infected cells, is the lack of a
suitable L protein antibody. This obstacle has been over-
come by using 2D-nLC-MSMS to examine the protein
content of the lipid-raft fraction directly. The statistical
analysis of the data identified nine unique peptide sequences
for the L protein, which produced a mascot score of 286
providing strong evidence for an association between this
protein and lipid-raft membrane structures.
The peak raft fraction from both mock- and virus-
infected cells was examined by transmission electronmicroscopy (TEM), which showed the presence of lipid
vesicles and protein material, the morphology of which was
indistinguishable in both samples (data not shown) and
which was similar to that reported previously in the TEM
analysis of lipid-raft preparations (Doyle et al., 1998).
Furthermore, the TEM analysis failed to detect the presence
of RNP structures in the raft preparation from virus-infected
cells (data not shown) suggesting that the polymerase
complex detected in the raft fraction may not have
assembled into the much larger herringbone-like structures
that are typical of RNPs and that can be clearly visualized in
virus preparations by TEM.
Inclusion bodies are located in regions of the cell that are
enriched in lipid rafts
The above data provided strong evidence that compo-
nents forming the viral polymerase associate with raft
lipids in infected cells. In virus-infected cells, these
proteins (N, P and M2-1), together with the M protein,
accumulate within structures referred to as inclusion bodies
(IB) (Garcia et al., 1993; Garcia-Barreno et al., 1996;
Ghildyal et al., 2002; Rixon et al., 2004). These structures
are easily visible in virus-infected cells by fluorescence
microscopy once they are labelled with an appropriate
antibody. Therefore, we examined infected cells to charac-
terise the cellular distribution of the IBs, with respect to
internal raft membranes and to determine if there was
cytological evidence for an association between IBs and
lipid rafts.
In this analysis, the IBs were detected using anti-RSV, a
composite antibody that recognises the N, P, and M2-1
proteins (Wright et al., 1997). The Golgi complex was
visualised using either the cis-Golgi specific antibody, anti-
GM130, or by using BODIPY Fl C5 ceramide to locate the
trans-Golgi. Cholera toxin B subunit conjugated to FITC
(CTX-B-FITC) was used as a probe to detect the presence of
the raft-lipid, GM1. In virus-infected cells stained with anti-
RSV and either anti-GM130 or BODIPY Fl C5 ceramide, it
was noted that the clearly visible IBs were located close to
the region of the cell that stained with these Golgi markers
(Figs. 5A,B). Several reports have suggested that specific
proteins are sorted into lipid-raft domains in the Golgi
network (reviewed in Brown and London, 1998; Ikonen,
2001; van Meer and Simons, 1988). Since the IBs
accumulate within the vicinity of the Golgi complex, this
implies that they may associate with membranous structures
of the secretory pathway.
In a further analysis, virus-infected cells were exposed
to CTX-B-FITC under normal culturing conditions (i.e., 33
8C), after which the cells were fixed and then labelled with
anti-RSV (Figs. 5C,D). Incubation of the infected cells
with CTX-B-FITC under these conditions allows internal
membranes containing GM1 that are located primarily
within the Golgi complex to be visualised by fluorescence
microscopy (Le and Nabi, 2003; Lencer et al., 1992, 1995,
Fig. 3. Identification of sequences, by mass spectrometry, that match RSV proteins. The ion scores, which demonstrate the quality of fit of the MSMS data
(scores N40 represent identity or close homology), are shown for each peptide identified. Mr(expt) and Mr(calc) are the experimentally determined and
expected masses (Da) respectively of the peptides and Delta = Mr(expt)  Mr(calc).
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Fig. 4. Sequence location of matched peptides within virus proteins
identified by the 2D-nLC-MSMS analysis. The complete sequence of each
protein identified by database comparison is shown. Peptide sequences that
were identified by mass spectrometry (bold type) are indicated.
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showed labelling with GM1, and the IBs were clearly
visible, this analysis revealed that the IBs contained only
very low levels of GM1 (denoted by a slight co-local-
isation within IBs). However, the IBs appeared to be
located within areas of the cell that contained high levels
of GM1, providing evidence that they accumulate in close
proximity to the raft-lipid, GM1. Although we have
focused on Hep2 cells in this paper, we have carried out
a similar analysis in BHK and Vero cells. In these other
cell lines, the inclusion bodies exhibited a much higher
level of CTX-B-FITC staining. This staining extended
across the entire inclusion body structure (data not shown),
suggesting that raft lipids are present throughout these
structures. The differences in CTX staining in these
different cell types is presumably due to cell-specific
differences in composition of raft lipids, i.e., the proportion
of GM1 in the total pool of raft lipids that is present in the
different cell types (de Mello Coelho et al., 2004).
Although the IBs represent major sites of accumulation
of the RNP-associated proteins within infected cells, it is
unclear to what extent the material from the IBs partition
into the raft fraction in the flotation gradients. However,
confocal microscopy results provide cytological evidence
suggesting that the N, P and M2-1 proteins are able to
associate with raft lipids within infected cells and support
the results from the proteomic analysis.
RSV polymerase activity is raft-associated
An association of the RSV polymerase complex with
lipid-raft membranes was supported by studies in which the
RNA polymerase activity present in lipid rafts from mock-
and RSV-infected cells was compared. In this study, the
RNA polymerase activity was assayed by measuring the
incorporation of [a-32P]UTP into newly synthesised RNA
using a filter binding assay (Barik, 1992). High levels of
RNA polymerase activity were present in lipid-raft mem-
branes isolated from RSV-infected cells, whereas corre-
sponding membranes from mock-infected cells showed
much lower levels of endogenous enzyme activity
(Fig. 6A). A further experiment was performed in which
each flotation gradient fraction was assayed for RNA
polymerase activity to determine if this activity was
confined to the lipid-raft fraction (Fig. 6B). In the gradient
prepared from virus-infected cells, approximately 95% of
the polymerase activity was present in the peak raft fraction
(fraction 3). A comparison of the polymerase activity and
protein levels in each fraction clearly showed an enrichment
of the enzyme activity within lipid-raft membranes,
Fig. 5. Cellular distribution of the IBs in virus-infected cells. RSV-infected cells were labelled with anti-RSV (red) and either (A) the Golgi marker GM130
(green) or (B) BODIPYR Fl C5 ceramide (cer) (green). Distribution of the IBs in relation to the Golgi markers (*) can be seen in the merged images. (C) Virus-
infected cells were incubated with CTX-B-FITC at 33 8C and labelled with anti-RSVas described in Materials and methods. The cellular distribution of the IBs
(red) and GM1 (green) is shown and co-localisation is indicated by the yellow staining pattern. (D) Distribution of the IBs and GM1 viewed in cross-section. In
this case, only the merged image is shown and co-localisation is indicated by the yellow staining pattern. The location of the IBs are highlighted (D).
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lipid rafts. The protein levels in each gradient fraction
revealed separation of the raft and non-raft fractions
(Fig. 6C) and the peak raft fraction accounted for only
approximately 20% of the total membrane-associated
protein present within the gradient. Furthermore, the N
and P proteins are major structural components of the viral
RNPs and although only relatively minor amounts of each
protein were detected in the peak raft fraction, the polymer-
ase activity was effectively confined to this fraction. This
correlation between RSV polymerase activity and the
presence of lipid-raft membranes suggests that an associa-
tion between the polymerase complex and raft membranes
is required for efficient polymerase activity.
An association between the replication complex of the
related paramyxovirus, Newcastle disease virus, with a cell
structure resistant to Triton X-100 extraction has been
reported (Hamaguchi et al., 1983). Although it is not clear if
an association between the polymerase complex and lipid
rafts is a common feature among paramyxoviruses, this
earlier result sets a precedent for our observation of a
membrane-association for the RSV polymerase complex.
However, the nature of the interaction between lipid rafts
and the RSV polymerase is currently undefined and it is
unclear if the polymerase is anchored to the raft membrane
via virus or host cell factors. It is interesting to note that
analysis of the M2-1 amino acid sequence suggests the
presence of hydrophobic regions in the protein that
theoretically could allow insertion of the protein into a
lipid membrane (Collins and Wertz, 1985). Furthermore, the
M2-1 protein appeared to show a greater affinity for thelipid raft membranes than all of the other RNP-associated
virus proteins (Fig. 1A). In addition, an interaction between
the M protein and lipid raft membranes in the absence of
other viral components has been demonstrated (Henderson
et al., 2002) and the M protein is able to interact with RNPs
in IBs (Ghildyal et al., 2002; Rodriguez et al., 2004).
Therefore, the possibility exists that an association of either
the M2-1 or the M protein and lipid membranes could
anchor the polymerase complex to lipid-raft membranes in
virus-infected cells. Alternatively, cytoskeleton-related host-
cell factors are required for transcription by several para-
myxoviruses (Carlsen et al., 1985; Peluso and Moyer, 1983;
Ray and Fujinami, 1987) and we have observed significant
levels of actin (Fig. 1A) and tubulin (data not shown) in the
peak raft fraction. Tubulin is required for efficient tran-
scription of Sendai virus RNA (Moyer et al., 1986) and the
role of actin in RSV gene expression has been documented
(Bitko et al., 2003; Burke et al., 1998; Huang et al., 1993).
Previous findings have demonstrated a physical and func-
tional association between actin and lipid rafts (Harder and
Simons, 1999; Valensin et al., 2002; Villalba et al., 2001)
and it is therefore possible that actin may be responsible for
the association of the viral polymerase complex with lipid-
raft membranes. A greater understanding of the cellular
distribution of the viral polymerase complex and the cellular
structures with which it interacts should aid our under-
standing of how host-cell factors influence the activity of
the viral polymerase. It can be speculated that the
association of the viral polymerase complex with lipid rafts
may serve in the recruitment or organisation of specific
cellular factors, such as actin, that are required for RSV
Fig. 6. RNA polymerase activity is associated with lipid-raft membranes in
RSV-infected cells. The assay, which was performed as described in
Materials and methods, measures the incorporation of [a-32P]UTP into
newly synthesised RNA. (A) Lipid-raft membranes from mock- and RSV-
infected cells were harvested as described in Materials and methods and the
polymerase activity measured at time intervals up to 120 min. (B)
Polymerase activity profile of the flotation gradient. The flotation gradients
were fractionated and the polymerase activity of each fraction measured
after 60 min. Each point represents the average counts per minute (cpm) of
duplicate samples, standard error b5%. (C) Protein concentration profile of
the flotation gradient.
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and functional significance of this association between the
viral polymerase complex and lipid-raft membranes remains
to be established.Materials and methods
Cells and viruses
The RSVA2 strain was used throughout this study. Hep2
cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum
(FCS) and antibiotics.
Antibodies and stains
The anti-RSV antibody was purchased from Novacastra
and the N, P, M and M2-1 protein antibodies were
obtained from Paul Yeo and John Steel (MRC Virology
Unit, Glasgow, UK). The Golgi-specific marker, GM130,
was provided by Martin Lowe (School of Biological
Sciences, University of Manchester). The cholera toxin B
subunit conjugated to FITC (CTX-B-FITC) and actin
antibody were purchased from Sigma Aldrich. The
caveolin-1 (N20) and transferrin receptor (tfr) antibodies
were purchased from Santa Cruz Biotechnology and
Zymed Laboratories, respectively. The trans-Golgi marker
BODIPY Fl C5 ceramide was purchased from Molecular
Probes.
Western blotting
Western blotting was performed as described previ-
ously (Brown et al., 2002a). Briefly, proteins were
separated by SDS PAGE, after which they were trans-
ferred by Western blotting on to PVDF membranes. The
membranes were washed, blocked with 1% Marvel and
probed with specific primary antibodies for 1 h. The
membranes were then washed, probed either with goat
anti-mouse or anti-rabbit IgG (whole molecule) peroxidase
conjugate (Sigma) as appropriate and the protein bands
visualised using the ECL protein detection system
(Amersham). Apparent molecular masses were estimated
using Rainbow protein markers (Amersham) in the
molecular weight range 14.3–220 kDa.
Immunofluorescence
Cells were seeded on 13-mm glass coverslips, infected
with RSV, and incubated overnight at 33 8C. The cells
were either fixed with 3% paraformaldehyde in PBS for
30 min at 4 8C or treated with CTX-B-FITC or BODIPY
Fl C5 ceramide for 30 min at 33 8C prior to fixation. The
cells were incubated for 1 h at room temperature with the
primary antibody, washed and then incubated for a further
1 h with goat anti-mouse IgG (whole molecule) con-
jugated to either FITC or Cy5 (1/100 dilution). The
stained cells were mounted on slides using Citifluor and
visualised with a Zeiss Axioplan 2 confocal microscope.
The images were processed using LSM 510 v2.01
software.
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Cell monolayers (5  107 cells) were washed twice with
PBSA and then twice with TM buffer (10mM Tris pH 7.4/
1 mM MgCl2) at 4 8C. The cells were scraped into TM
buffer supplemented with an EDTA-free protease-inhibitor
mixture (Roche Molecular Biochemicals) and Dounce
homogenised (80 strokes). Unbroken cells and nuclei were
removed by centrifugation at 1000  g for 5 min. The
1000  g supernatant was centrifuged at 45000  g for
15 min to pellet the membranes that were then washed in
TM buffer supplemented with protease-inhibitors. Mem-
branes were resuspended in 1% Triton X-100, 2 mM
EDTA in PBS for 1.5 h at 4 8C with occasional Dounce
homogenisation. The homogenate was added to an equal
volume of 80% (w/v) sucrose in 10 mM Tris pH 7.4/150
mM NaCl/1 mM EDTA (TNE). The solubilised mem-
branes (in 40% sucrose) were placed at the bottom of a
centrifuge tube and overlaid successively with 7 ml 35%
sucrose and 2 ml 5% sucrose in TNE. After centrifugation
at 210000  g for 18 h, the gradient was fractionated and
the individual fractions analysed by Western blotting using
appropriate antibodies.
RNA polymerase assay
RNA polymerase activity was measured using a filter
binding assay described previously (Barik, 1992). Lipid-raft
membranes (0.1–3 Ag total protein), prepared by flotation
gradient, were incubated at 37 8C in the following reaction
mixture: 50 mM Tris–HCl, pH 8.0; 100 mM K-Ac; 5 mM
MgCl2; 1 mM DTT; 500 AM each of CTP and GTP; 1 mM
ATP; 30 AM [a-32P]UTP; 0.04 Ag actinomycin D; 5%
glycerol; 400 units RNasin in a total volume of 20 Al. At
various time intervals, 4-Al samples were applied to 2.3 cm
DE81 discs (Whatman) and left to air dry. The discs were
then washed six times in 0.5 M Na2HPO4 (with gentle
agitation), before being dried under a heat lamp. Scintilla-
tion fluid was added and the discs were counted in a
Beckman LS5000CE scintillation counter.
Protein determination
Protein concentrations were determined using the 2-D
Quant Kit (Amersham Biosciences).
Two-dimensional nanoflow liquid chromatography mass
spectrometry (2D-nLC-MSMS)
The lipid-raft fraction was harvested from the flotation
gradient prior to precipitation in 6% TCA/60 mM sodium
deoxycholate (final concentrations). Pellets were resus-
pended at a concentration of approximately 5 mg/ml in
100 mM Tris pH 7.5 containing 1% octyl-h-glucoside, 6 M
urea and 2 M thiourea by a combination of vigorous mixing(30 min) and ultrasonic disruption (3  5 min with 5-min
gaps) at room temperature. The sample was then diluted 1
in 10 with trypsin (Promega modified sequencing grade,
porcine, 20 Ag per 500 Ag of raft protein) in 20 mM
ammonium bicarbonate. The samples were digested over-
night at 37 8C, acidified with 5% formic acid and stored
frozen until required. For 2D-nLC-MSMS, the thawed
samples were cleared by centrifugation (10000  g, 10
min) and the supernatant decanted. The equivalent of
approximately 200 Ag of protein was used for each
nanoflow liquid chromatography run. Each sample was
subjected to 2D-nLC-MSMS on a QStar Pulsar electrospray
mass spectrometer fitted with a nanospray source (Protana),
using a 20-Am i.d., 10 Am orifice distally coated electro-
spray tip mounted in a ProADP2 adaptor (New Objective).
This was connected to a nanoflow LC system (LC
Packings/Dionex: Famos, Switchos and Ultimate compo-
nents) with the minimum length possible of 20-Am i.d.
fused silica capillary tubing. 2D-LC was performed using a
0.5  15 mm SAX (BioX-SCX) trap, a 0.3  5 mm
reversed phase trap (PepMap C18) and a 75 Am  15 cm
PepMap C18 reversed phase column using standard
methodology with a loading pump flow of 30 Al min1
and a main flow of 200 nl min1. Nine increasing salt
concentration steps were used in the salt elution: wash-
through, 25, 50, 75, 100, 150, 200, 300 and 1000 mM KCl,
eluting with 40 Al of salt solution in each case. Eluted
peptides were trapped on the C18 trap for 5 min and
desalted for 7 min before being separated with a 5–40%
acetonitrile, 0.5% formic acid gradient over 90 min.
Mass spectrometric analysis was performed in IDA mode
(AnalystQS software, Applied Biosystems), selecting the
four most intense ions for MSMS analysis. A survey scan of
400–1500 Da was collected for 3 s followed by 5 sec MSMS
scans of 50–2000 Da using the standard rolling collision
energy settings. Masses were then added to the exclusion list
for 3 min. Peaks were extracted using the Mascot script
(BioAnalyst, Applied Biosystems) and automatically
exported to the Mascot (Matrix Science) search engine.
The peptide sequences identified were matched against
either the NCBInr human or virus database using the Mascot
Daemon, with a peptide tolerance of 1.5 Da and a MSMS
ion tolerance of 0.5 Da allowing for two missed cleaves and
variable methionine oxidation. Specific proteins are
matched with the identified peptides and each protein is
assigned a mascot score, which is a probability-based
Mowse score (Perkins et al., 1999). The Mascot score is
equal to 10 log(P), where P is the estimated probability
that the observed match is a random event. For example, a
score of 100 represents a 1 in 1010 chance that the protein
match is a random event providing a high degree of
certainty to the identity of the protein in question. An
objective measure of the significance of the result is then
given by a threshold representing a point at which the
identification would be expected to occur at random with a
frequency of less than 5%.
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